The current pathophysiological concept understands TTP as a state of severe deficiency of ADAMTS13, which can be caused either by genetic abnormalities (congenital TTP) or by autoantibodies affecting function or clearance of ADAMTS13 (autoimmune TTP). Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.